atezolizumab,xl092
exelixis,roche
['xl092', 'xl092 ', 'stellar-001', 'solid tumor', 'exelixis']
exelixis announces dose-escalation results from the phase 1 stellar-001 trial evaluating xl092 alone and in combination with an immune checkpoint inhibitor in patients with advanced solid tumors at esmo 2022 #stocksmarket #pressrelease
Stock Market News and Press Releases. #StockMarket & #Crypto